Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains  53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead of diet and exercise. Over half of respondents get quality sleep on only four nights a week or less.

GlobeNewsWire • Mar 3, 2026

ResMed At $250: Missed Opportunity Or A Trap In The Making?

ResMed (RMD) stock is currently at a fascinating juncture. It is trading at a low price, and if you decide to invest in it, you are wagering on a company that is demonstrating reasonable growth, maintaining solid cash flow and margin, has a low-debt capital structure, and is fairly valued.

Forbes • Feb 25, 2026

4 GARP Stocks That Investors Can Scoop Up for Maximum Returns

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RL, EAT, FTI and RMD hold promise.

Zacks Investment Research • Feb 25, 2026

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution center in Greenwood, Indiana. Scheduled to begin operations in 2027, the center will expand Resmed's U.S. presence and strengthen the company's distribution capacity to better serve patients and providers across North America.

GlobeNewsWire • Feb 24, 2026

Invesco International Growth Fund Q4 2025 Portfolio Update

Invesco International Growth Fund underperformed most in industrials, consumer discretionary and communication services, all due to stock selection. We initiated five positions during the quarter, four of which we can discuss now. We eliminated seven positions. Relative to its index, the fund outperformed most in financials, health care and energy, all due to stock selection.

Seeking Alpha • Feb 16, 2026

Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns

The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. APH, GE, RMD and AMP are some such stocks.

Zacks Investment Research • Feb 9, 2026

RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand

Resmed shares rise after Q2 EPS and revenues beat expectations, with the gross and operating margins expanding sharply across core segments.

Zacks Investment Research • Feb 6, 2026

Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge

Sleep-breathing device maker ResMed plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style weight loss drugs for apnea, calling the GLP‑1 boom a lift, not a threat, to sales.

Reuters • Feb 3, 2026

4 Medical Product Stocks to Watch From a Challenging Industry (Revised)

The Zacks Medical Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.

Zacks Investment Research • Feb 3, 2026

4 Medical Product Stocks to Watch From a Challenging Industry

The Zacks Medical products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.

Zacks Investment Research • Feb 2, 2026